🟢 Harrow Health is trading 5.71% up today after upgrade to cautious Buy

Harrow Health is trading 5.71% up at $41.09 on August 14, 2026, after a recent upgrade from Hold to a cautious Buy.

• The upgrade cited improved second-quarter execution, stronger VEVYE economics, and better operating-leverage visibility.
• The rebound follows an earnings-driven selloff after Harrow reported a wider-than-expected loss despite revenue growth, while outperforming a weaker market.